| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W |
| P698 | PubMed publication ID | 12209625 |
| P50 | author | Britta Engelhardt | Q43814115 |
| P2093 | author name string | Carsten Alt | |
| Melanie Laschinger | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | blood–brain barrier | Q221694 |
| P304 | page(s) | 2133-2144 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephal | |
| P478 | volume | 32 |
| Q48879804 | Adjuvant immunotherapy of C6 glioma in rats with pertussis toxin. |
| Q35136409 | CCR7 directs the recruitment of T cells into inflamed pancreatic islets of nonobese diabetic (NOD) mice |
| Q90638165 | CD8 T-cell Recruitment Into the Central Nervous System of Cuprizone-Fed Mice: Relevance to Modeling the Etiology of Multiple Sclerosis |
| Q24642697 | CNS immune privilege: hiding in plain sight |
| Q34965558 | CXCL1 contributes to β-amyloid-induced transendothelial migration of monocytes in Alzheimer's disease |
| Q40775503 | Central Nervous System Stromal Cells Control Local CD8(+) T Cell Responses during Virus-Induced Neuroinflammation |
| Q36065424 | Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis |
| Q28263920 | Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo |
| Q98779141 | Characterization of a Murine Model of Oxazolone-Induced Orbital Inflammation |
| Q47129845 | Chemokine and cytokine levels in the lumbar cerebrospinal fluid of preterm infants with post-hemorrhagic hydrocephalus |
| Q36234166 | Chemokine control of lymphocyte trafficking: a general overview. |
| Q37091531 | Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses |
| Q48829652 | Chemokines and chemokine receptors in inflammation of the CNS. |
| Q35771258 | Chemokines and glial cells: a complex network in the central nervous system. |
| Q41935478 | Chemokines in inflammatory bowel disease |
| Q38219641 | Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers. |
| Q36718940 | Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders. |
| Q24623805 | Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis |
| Q44757991 | Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease |
| Q37723420 | DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation |
| Q46409637 | Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients. |
| Q35648177 | Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10. |
| Q37440145 | Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis |
| Q37075235 | Ectopic lymphoid tissues and local immunity |
| Q46919125 | Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain |
| Q34792995 | Enhanced Chemokine Receptor Expression on Leukocytes of Patients with Alzheimer's Disease |
| Q47661247 | Expression of CCR7 in multiple sclerosis: implications for CNS immunity |
| Q44029123 | Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis. |
| Q21195861 | Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle |
| Q37112554 | G protein-coupled receptors as therapeutic targets for multiple sclerosis |
| Q57057826 | Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention |
| Q36593767 | Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors |
| Q35140815 | Immune responses to RNA-virus infections of the CNS. |
| Q36832873 | Immunopathogenesis of multiple sclerosis |
| Q41831341 | Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta |
| Q38156767 | Initial immunopathogenesis of multiple sclerosis: innate immune response. |
| Q36884649 | Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS. |
| Q38710997 | Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis |
| Q24801279 | Involvement of beta-chemokines in the development of inflammatory demyelination |
| Q37186200 | Lymphoid chemokines in chronic neuroinflammation |
| Q34020894 | Lymphoid chemokines in the CNS. |
| Q35205899 | MIP-3β/CCL19 is associated with the intrathecal invasion of mononuclear cells in neuroinflammatory and non-neuroinflammatory CNS diseases in dogs |
| Q35748581 | Mechanisms of dendritic cell trafficking across the blood-brain barrier |
| Q37608080 | Modeling multiple sclerosis in laboratory animals. |
| Q36426872 | Molecular mechanisms involved in T cell migration across the blood-brain barrier. |
| Q37776054 | Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms |
| Q33772195 | Myelin recovery in multiple sclerosis: the challenge of remyelination |
| Q34433743 | Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. |
| Q53382755 | Nociceptin/orphanin FQ inhibition with SB612111 ameliorates dextran sodium sulfate-induced colitis. |
| Q38356616 | Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array |
| Q48151397 | Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates |
| Q39003384 | PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE. |
| Q48325664 | Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. |
| Q47992175 | Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria |
| Q36372950 | Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines |
| Q37800163 | Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain |
| Q36366897 | Rituximab combination therapy in relapsing multiple sclerosis |
| Q36146400 | Role of C-C chemokine receptor type 7 and its ligands during neuroinflammation |
| Q36742483 | Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues |
| Q38088289 | Seminal fluid and the generation of regulatory T cells for embryo implantation. |
| Q36926874 | Structural reorganization of the dentate gyrus following entorhinal denervation: species differences between rat and mouse |
| Q38020964 | T-cell trafficking in the central nervous system |
| Q58199700 | TET inducible expression of the α4β7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis |
| Q28071379 | Tertiary Lymphoid Organs in Central Nervous System Autoimmunity |
| Q39186373 | The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases |
| Q91839167 | The anatomy and immunology of vasculature in the central nervous system |
| Q28299076 | The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting |
| Q37778548 | The blood–brain barrier, chemokines and multiple sclerosis |
| Q36726766 | The role of chemokines during herpes simplex virus-1 infection |
| Q37706120 | The role of dendritic cells in CNS autoimmunity |
| Q36027486 | The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis. |
| Q47859915 | To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis. |
| Q33815795 | Trafficking of immune cells in the central nervous system |
| Q37089055 | Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells |
| Q44219240 | VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. |
| Q40383984 | Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. |
Search more.